Inhaled Corticosteroids and Risk of Upper Respiratory Tract Infection in Patients with Asthma: a Meta-analysis

Overview

Journal Infection

Date 2018 Oct 10

PMID 30298471

Citations 33

Authors

Mingjin Yang

Yan Zhang

Hong Chen

Jiachen Lin

Jiatao Zeng

Zhibo Xu

Affiliations

Soon will be listed here.

Abstract

Background: Recent studies have suggested a possible association between respiratory infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper respiratory tract infection (URTI) with long-term inhaled corticosteroid use among patients with asthma.

Methods: Through a comprehensive literature search of PubMed, Cochrane Library, EMBASE, and Google Scholar from inception to May 2018, we included randomized controlled trials of any ICS vs. a control treatment for asthma, with reporting of URTI as an adverse event. We conducted meta-analyses by the Peto approaches to generate summary estimates comparing ICS with non-ICS treatment on the risk of URTI.

Results: Seventeen trials (15,336 subjects) were included. Compared with non-ICS treatment, ICSs were associated with a significantly increased risk of URTI (Peto OR, 1.24; 95% CI 1.08-1.42; I = 5%, p = 0.002). Subgroup analyses were performed for different dose, both high- and low-dose ICSs were associated with a significantly increased risk of URTI (high dose: Peto OR, 1.46; 95% CI 1.05-2.03; I = 0%; p = 0.03) (low dose: Peto OR, 1.20; 95% CI 1.04-1.39; I = 25%; p = 0.01). Moreover, fluticasone was observed with an increased risk of URTI (Peto OR, 1.18; 95% CI 1.02-1.38; p = 0.03; heterogeneity: I = 21%) but not budesonide, low-dose fluticasone treatment was associated with a significantly higher risk of URTI but not high dose.

Conclusions: This study raises safety concerns about the risk of URTI associated with ICS use in patients with asthma, but it should be further investigated.

Citing Articles

Protective Effect of Allergen Immunotherapy in Patients With Allergic Rhinitis and Asthma Against COVID-19 Infection: Observational, Nationwide, and Multicenter Study.

Qin R, Feng Y, Zhang H, Zhao B, Lei W, Sun H JMIR Public Health Surveill. 2024; 10:e50846.

PMID: 39412952 PMC: 11498206. DOI: 10.2196/50846.

Relationship between steroid use and superinfections in SARS-CoV-2 patients. A systematic review and meta-analysis.

Gonzalez Ramirez M, Hoyos Munoz J, Moreno Gomez G, Florez M, Gomez Gonzalez J Infect Ecol Epidemiol. 2024; 13(1):2277000.

PMID: 38187166 PMC: 10769522. DOI: 10.1080/20008686.2023.2277000.

Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid.

Yong S, Gau S, Li C, Tseng C, Wang S, Cheng-Chung Wei J Front Pharmacol. 2023; 14:1204297.

PMID: 38027036 PMC: 10646298. DOI: 10.3389/fphar.2023.1204297.

Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease 2019: A living review and meta-analysis.

Yu S, Choi M, Ryoo S, Cheong C, Huh K, Yoon Y PLoS One. 2023; 18(11):e0294872.

PMID: 38015868 PMC: 10684004. DOI: 10.1371/journal.pone.0294872.

Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study.

Huang Y, Chen C, Cen L, Li H, Lin Z, Zhu S Emerg Microbes Infect. 2023; 12(1):2202277.

PMID: 37038356 PMC: 10167879. DOI: 10.1080/22221751.2023.2202277.

References

Chapman K, Patel P, DUrzo A, Alexander M, Mehra S, Oedekoven C . Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy. 2005; 60(3):330-7. DOI: 10.1111/j.1398-9995.2004.00750.x. View

Sheffer A, Silverman M, Woolcock A, Diaz P, Lindberg B, Lindmark B . Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. Ann Allergy Asthma Immunol. 2005; 94(1):48-54. DOI: 10.1016/S1081-1206(10)61285-9. View

DUrzo A, Karpel J, Busse W, Boulet L, Monahan M, Lutsky B . Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. Curr Med Res Opin. 2005; 21(8):1281-9. DOI: 10.1185/030079905X56402. View

Lumry W, Conway M, LaForce C, Pearlman D, Scott C, Herje N . Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids. Ann Allergy Asthma Immunol. 2006; 96(1):51-9. DOI: 10.1016/S1081-1206(10)61040-X. View

Nathan R, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K . Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week.... Clin Ther. 2006; 28(1):73-85. DOI: 10.1016/j.clinthera.2006.01.008. View

Karpel J, Nayak A, Lumry W, Craig T, Kerwin E, Fish J . Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Respir Med. 2006; 101(3):628-37. DOI: 10.1016/j.rmed.2006.06.005. View

Noonan M, Rosenwasser L, Martin P, OBrien C, ODowd L . Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs. 2006; 66(17):2235-54. DOI: 10.2165/00003495-200666170-00006. View

Calverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007; 356(8):775-89. DOI: 10.1056/NEJMoa063070. View

Corren J, Korenblat P, Miller C, OBrien C, Mezzanotte W . Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther. 2007; 29(5):823-843. DOI: 10.1016/j.clinthera.2007.05.011. View

10.

Suissa S, McGhan R, Niewoehner D, Make B . Inhaled corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007; 4(7):535-42. DOI: 10.1513/pats.200701-024FM. View

11.

Chuchalin A, Jacques L, Frith L . Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids. Clin Drug Investig. 2008; 28(3):169-81. DOI: 10.2165/00044011-200828030-00004. View

12.

Singh S, Amin A, Loke Y . Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med. 2009; 169(3):219-29. DOI: 10.1001/archinternmed.2008.550. View

13.

Brassard P, Lowe A, Bernatsky S, Kezouh A, Suissa S . Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum. 2009; 61(3):300-4. DOI: 10.1002/art.24476. View

14.

Busse W, Bleecker E, Bateman E, Lotvall J, Forth R, Davis A . Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial. Thorax. 2011; 67(1):35-41. DOI: 10.1136/thoraxjnl-2011-200308. View

15.

Woodcock A, Bateman E, Busse W, Lotvall J, Snowise N, Forth R . Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial. Respir Res. 2011; 12:132. PMC: 3217852. DOI: 10.1186/1465-9921-12-132. View

16.

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

17.

Woodcock A, Bleecker E, Busse W, Lotvall J, Snowise N, Frith L . Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma. Respir Res. 2011; 12:160. PMC: 3282675. DOI: 10.1186/1465-9921-12-160. View

18.

Juniper E, KLINE P, Vanzieleghem M, Ramsdale E, OByrne P, Hargreave F . Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis. 1990; 142(4):832-6. DOI: 10.1164/ajrccm/142.4.832. View

19.

Zhang L, Prietsch S, Mendes A, Groll A, Rocha G, Carrion L . Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma. Respirology. 2012; 18(2):272-7. DOI: 10.1111/j.1440-1843.2012.02280.x. View

20.

Oliver A, Bjermer L, Quinn D, Saggu P, Thomas P, Yarnall K . Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination. Allergy. 2013; 68(9):1136-42. PMC: 4223930. DOI: 10.1111/all.12205. View